Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × 89Zr-bevacizumab × Endocrine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1 CNS 1 Breast 1

Conditions

Neuroendocrine Tumors 1

Interventions

Surveys and Questionnaires 7 Blood Specimen Collection 7 lutetium Lu 177 dotatate 6 Surgical Procedures, Operative 6 Magnetic Resonance Spectroscopy 6 Adrenalectomy 5 Observation 4 Transurethral Resection of Prostate 3 Thyroidectomy 3 Positron-Emission Tomography 3 Lymph Node Excision 3 Data Collection 3 telotristat ethyl 2 gallium Ga 68 dotatate 2 Somatostatin 2 Radionuclide Imaging 2 Radiofrequency Ablation 2 Everolimus 2 Biopsy 2 surufatinib 1 somapacitan 1 methyl hydroxyethyl cellulose 1 lanreotide 1 exemestane 1 delta 24-sterol reductase 1 copper dotatate CU-64 1 Whole Body Imaging 1 Walking 1 Visual Field Tests 1 Visual Acuity 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01338090 2012-04-03

NETPET

University Medical Center Groningen

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡